Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 2.66M
2: EX-10.1 EX-10.1 Second Amended and Restated Cic HTML 100K
3: EX-10.2 EX-10.2 Second Amended and Restated Cic Thomas HTML 100K
Deitrich
4: EX-31.1 EX-31.1 Section 302 CEO Certification HTML 33K
5: EX-31.2 EX-31.2 Section 302 CFO Certification HTML 33K
6: EX-32.1 EX-32.1 Section 906 CEO and CFO Certifications HTML 30K
12: R1 Cover Page HTML 81K
13: R2 Consolidated Statements of Operations HTML 139K
14: R3 Consolidated Statements of Comprehensive Income HTML 72K
(Loss)
15: R4 Consolidated Balance Sheets HTML 156K
16: R5 Consolidated Balance Sheets (Parenthetical) HTML 44K
17: R6 Consolidated Statements of Equity Statement HTML 118K
18: R7 Consolidated Statements of Cash Flows HTML 140K
19: R8 Summary of Significant Accounting Policies HTML 40K
20: R9 Earnings Per Share HTML 55K
21: R10 Certain Balance Sheet Components HTML 73K
22: R11 Intangible Assets and Liabilities HTML 82K
23: R12 Goodwill HTML 45K
24: R13 Debt HTML 61K
25: R14 Derivative Financial Instruments HTML 108K
26: R15 Defined Benefit Pension Plans HTML 60K
27: R16 Stock-Based Compensation HTML 104K
28: R17 Income Taxes HTML 51K
29: R18 Commitments and Contingencies HTML 75K
30: R19 Restructuring (Notes) HTML 79K
31: R20 Shareholders' Equity HTML 121K
32: R21 Fair Values of Financial Instruments HTML 46K
33: R22 Segment Information HTML 125K
34: R23 Revenue Recognition HTML 43K
35: R24 Sale of Business HTML 33K
36: R25 Summary of Significant Accounting Policies HTML 39K
(Policies)
37: R26 Earnings Per Share (Tables) HTML 49K
38: R27 Certain Balance Sheet Components (Tables) HTML 83K
39: R28 Intangible Assets and Liabilities (Tables) HTML 86K
40: R29 Goodwill (Tables) HTML 45K
41: R30 Debt (Tables) HTML 46K
42: R31 Derivative Financial Instruments (Tables) HTML 110K
43: R32 Defined Benefit Pension Plans (Tables) HTML 56K
44: R33 Stock-Based Compensation (Tables) HTML 107K
45: R34 Income Taxes (Tables) HTML 44K
46: R35 Commitments and Contingencies (Tables) HTML 74K
47: R36 Restructuring (Tables) HTML 78K
48: R37 Shareholders' Equity (Tables) HTML 113K
49: R38 Fair Values of Financial Instruments (Tables) HTML 42K
50: R39 Segment Information (Tables) HTML 120K
51: R40 Revenue Recognition (Tables) HTML 36K
52: R41 Summary of Significant Accounting Policies HTML 32K
(Details)
53: R42 Computation of Basic and Diluted Earnings per HTML 65K
Share (Details)
54: R43 Earnings Per Share Stock-based Awards (Details) HTML 30K
55: R44 Earnings Per Share - Convertible Senior Notes and HTML 40K
Warrants (Details)
56: R45 Earnings Per Share - Convertible Note Hedge HTML 37K
Transactions (Details)
57: R46 Certain Balance Sheet Components Accounts HTML 36K
Receivable, Net (Details)
58: R47 Certain Balance Sheet Components Summary of the HTML 37K
Allowance for Doubtful Accounts (Details)
59: R48 Certain Balance Sheet Components Inventories HTML 38K
(Details)
60: R49 Certain Balance Sheet Components Property, Plant, HTML 47K
and Equipment, Net (Details)
61: R50 Certain Balance Sheet Components Depreciation HTML 30K
Expense (Details)
62: R51 Intangible Assets and Liabilities Gross Carrying HTML 58K
Amount and Accumulated Amortization (Details)
63: R52 Summary of Intangible Asset Account Activity HTML 36K
(Details)
64: R53 Intangible Assets and Liabilities Estimated Future HTML 69K
Annual Amortization Expense (Details)
65: R54 Schedule of Goodwill Allocated to Reporting HTML 51K
Segments (Details)
66: R55 Debt - Schedule of Debt Components of Borrowing HTML 49K
(Details)
67: R56 Debt - Credit Facility Additional Information HTML 106K
(Details)
68: R57 Debt - Convertible Note Additional Information HTML 43K
(Details)
69: R58 Debt - Minimum Required Principal Payments HTML 48K
(Details)
70: R59 Derivative Financial Instruments - Derivative and HTML 45K
Nonderivative Hedging Instrument Fair Value
Disclosure (Details)
71: R60 Derivative Financial Instruments - Activity of HTML 40K
Hedging Instruments in Accumulated OCI (Details)
72: R61 Derivative Financial Instruments - Narrative HTML 79K
(Details)
73: R62 Derivative Financial Instruments - Offsetting of HTML 40K
Derivative Assets (Details)
74: R63 Derivative Financial Instruments - Offsetting of HTML 40K
Derivative Liabilities (Details)
75: R64 Derivative Financial Instruments - Effect of Cash HTML 59K
Flow Derivatives on the Balance Sheet and Income
Statement, Before Tax (Details)
76: R65 Derivative Financial Instruments - Derivatives Not HTML 32K
Designated as Hedging Relationships (Details)
77: R66 Schedule of Amounts Recognized in the Consolidated HTML 38K
Balance Sheets (Details)
78: R67 Schedule of Net Periodic Pension Benefit Costs HTML 48K
(Details)
79: R68 Stock-Based Compensation Expense and Related Tax HTML 44K
Benefit (Details)
80: R69 Stock Option Summary (Details) HTML 79K
81: R70 Stock-Based Compensation Restricted Stock Units HTML 66K
Summary (Details)
82: R71 Stock-Based Compensation Long-Term Performance HTML 42K
Restricted Stock Unit Award Monte Carlo Pricing
Model Assumptions (Details)
83: R72 Stock-Based Compensation Narrative (Details) HTML 50K
84: R73 Income Tax Contingencies (Details) HTML 39K
85: R74 Income Taxes Narrative (Details) HTML 33K
86: R75 Commitments and Contingencies Available Lines of HTML 55K
Credit, Outstanding Standby Letter of Credits, and
Bonds (Details)
87: R76 Commitments and Contingencies Warranty Account HTML 46K
Activity (Details)
88: R77 Commitments and Contingencies Warranty Expense HTML 30K
(Details)
89: R78 Restructuring Expected Costs - 2021 Projects HTML 54K
(Details)
90: R79 Restructuring Expected Costs - 2020 Projects HTML 54K
(Details)
91: R80 Restructuring Additional Information (Details) HTML 34K
92: R81 Restructuring Related Balance Sheet Activity HTML 54K
(Details)
93: R82 Shareholders' Equity Narrative (Details) HTML 77K
94: R83 Shareholders' Equity Accumulated Other HTML 80K
Comprehensive Income (Details)
95: R84 Shareholders' Equity Other Comprehensive Income HTML 95K
(Loss) (Details)
96: R85 Schedule of Fair Values of Financial Instruments HTML 44K
(Details)
97: R86 Segment Information Narrative (Details) HTML 30K
98: R87 Information By Segment (Details) HTML 76K
99: R88 Segment Information Revenues By Region (Details) HTML 41K
100: R89 Depreciation and Amortization, by Segment HTML 40K
(Details)
101: R90 Revenue Recognition Revenue Contract Assets and HTML 40K
Liabilities Rollforward (Details)
102: R91 Revenue Recognition Narrative (Details) HTML 33K
103: R92 Revenue Recognition Remaing Performance Obligation HTML 37K
(Details)
104: R93 Sale of Business - Narrative (Details) HTML 52K
107: XML IDEA XML File -- Filing Summary XML 198K
105: XML XBRL Instance -- itri-20220630_htm XML 3.20M
106: EXCEL IDEA Workbook of Financial Reports XLSX 199K
8: EX-101.CAL XBRL Calculations -- itri-20220630_cal XML 282K
9: EX-101.DEF XBRL Definitions -- itri-20220630_def XML 800K
10: EX-101.LAB XBRL Labels -- itri-20220630_lab XML 2.04M
11: EX-101.PRE XBRL Presentations -- itri-20220630_pre XML 1.30M
7: EX-101.SCH XBRL Schema -- itri-20220630 XSD 209K
108: JSON XBRL Instance as JSON Data -- MetaLinks 503± 783K
109: ZIP XBRL Zipped Folder -- 0000780571-22-000020-xbrl Zip 574K
1.I have reviewed this Quarterly Report on Form 10-Q of Itron, Inc.;
2.Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying
officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period
in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant's internal control over financial reporting.
